Hydrogenics Corporation (USA)  

(Public, NASDAQ:HYGS)   Watch this stock  
Find more results forHYGS
21.38
+0.73 (3.54%)
Aug 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.60 - 21.66
52 week 11.00 - 35.52
Open 20.60
Vol / Avg. 91,467.00/168,840.00
Mkt cap 213.94M
P/E     -
Div/yield     -
EPS -0.83
Shares 10.09M
Beta 0.19
Inst. own 4%
Sep 18, 2014
Hydrogenics Corp at Craig-Hallum Alpha Select Conference Add to calendar
Aug 13, 2014
Hydrogenics Corp at Canaccord Genuity Growth Conference
Aug 7, 2014
Hydrogenics Corp at Needham Advanced Industrial Technologies Conference
Jul 30, 2014
Q2 2014 Hydrogenics Corp Earnings Call
Jul 30, 2014
Q2 2014 Hydrogenics Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -1.17% -21.00%
Operating margin 3.23% -15.99%
EBITD margin - -14.31%
Return on average assets -1.02% -21.74%
Return on average equity -4.72% -170.19%
Employees 140 -
CDP Score - -

Address

220 Admiral Boulevard
MISSISSAUGA, ON L5T 2N6
Canada
+1-905-3613660 (Phone)
+1-905-3613626 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hydrogenics Corporation, together with its subsidiaries, designs, develops and provides hydrogen generation and fuel cell products based on water electrolysis technology and proton exchange membrane (PEM) technology. The Company conducts its business through two business units: OnSite Generation, which focuses on hydrogen generation products for renewable energy, industrial and transportation customers, and Power Systems, which focuses on fuel cell products for original equipment manufacturers (OEMs) systems integrators and end users for stationary applications, including backup power, and motive applications, such as forklift trucks. The Company�s products include HySTAT hydrogen generation equipment in its OnSite Generation business and HyPM fuel cell products in its Power Systems business. The Company maintains operations in Belgium, Canada and Germany.

Officers and directors

Douglas S. Alexander Independent Chairman of the Board
Bio & Compensation  - Reuters
Daryl C. F. Wilson President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Robert Motz Chief Financial Officer, Corporate Secretary
Bio & Compensation  - Reuters
Joseph Cargnelli Chief Technology Officer, Director
Bio & Compensation  - Reuters
Wido Westbroek Vice President - Sales and Marketing
Bio & Compensation  - Reuters
Filip Smeets General Manager - OnSite Generation
Bio & Compensation  - Reuters
Donald James Lowry Director
Age: 62
Bio & Compensation  - Reuters
Michael Cardiff Independent Director
Bio & Compensation  - Reuters
Henry J. Gnacke Independent Director
Bio & Compensation  - Reuters